| Synonyms |
| Zonegran |
| SPECIMEN REQUIREMENTS |
|
| Container Type |
| Red top tube (plain) |
| Supply Item Number |
| 1372 |
| Specimen Type |
| Serum |
| Preferred Volume |
| 1.5 mL |
| Emergency Minimum Volume |
| 0.8 mL |
| Patient Prep |
| Timing of specimen collection: Pre-dose (trough) draw - At steady state concentration. |
| Specimen Processing |
| Separate serum or plasma from cells ASAP or within 2 hours of collection and transfer to a standard PAML aliquot tube. |
| Store and Transport |
| Refrigerated |
| Stability |
| Room Temp 1 week Refrigerated 1 week Frozen (-20 °C) 1 month |
| Unacceptable Condition |
| Whole blood; serum or plasma separator tubes; grossly hemolyzed specimens |
| Alternate Specimens |
| Lavender (EDTA), pink (K2EDTA), or green (sodium or lithium heparin) |
| Limitations |
| If testing is to be delayed by more than 1 week, specimens should be stored frozen for up to 1 month prior to being tested. Avoid repeated freezing and thawing of the specimen. |
| Reference Laboratory |
| PAML |
| CPT Codes |
| 80203 |
| Interface Order Code |
| 80299.Z53 |
| Billing Code |
| ZONI |
| Test Schedule |
| Mon-Fri |
| Turnaround Time |
| 1-3 days |
| Method |
| PETIA |
| Reference Ranges |
| Title | Ranges | Units | | Zonisamide | 10.0-40.0 | ug/mL | | The proposed therapeutic range for seizure control is 10.0-40.0 ug/mL. Concentrations that exceed 80.0 ug/mL, may contribute to adverse effects. | | Pharmacokinetics varies widely, particularly with co-medications and/or compromised renal function. |
|
